{"id":680,"date":"2017-04-02T16:42:33","date_gmt":"2017-04-02T16:42:33","guid":{"rendered":"http:\/\/www.besthealthsciencedegree.com\/?page_id=680"},"modified":"2017-03-31T16:47:34","modified_gmt":"2017-03-31T16:47:34","slug":"5-facts-about-drug-patents","status":"publish","type":"page","link":"http:\/\/www.besthealthsciencedegree.com\/lists\/5-facts-about-drug-patents\/","title":{"rendered":"5 Facts About Drug Patents"},"content":{"rendered":"
The legal drug and pharmaceutical industry is one of the largest financial interests in the United States. It has seen its fair share of controversy, particularly in recent years, but the development of new drugs remains one of the most critical aspects of modern life. Part of the process of developing drugs is the filing for drug patents<\/a>, which helps the major pharmaceutical corporations recoup the tremendous expense involved in researching, developing, fielding, and marketing new medications.<\/p>\n Here are five little-known facts about drug patents, which many people entering into medical and pharmacological degree programs aren’t necessarily aware of:<\/p>\n Patent medicine, the practice of protecting drugs with patents, began in England in the 17th century. At that time, government standards were significantly more lax, and record-keeping was a far more tedious challenge. As such, the prevailing attitude of the day was “buyer beware;” in order to score a patent, a newly manufactured drug had only to be original. There were no standards in place to measure its safety, or whether or not it actually treated any of the conditions connected to its marketing campaign. Early perception of government endorsement, coupled with the guarantee of exclusivity, led to these medications being marketed to treat an astonishing array of dozens of unrelated conditions, ultimately leading to “patent medicines” entering the public lexicon as a disparaging term.<\/p>\n Today, we have clinical trials which are meant to ensure the relative safety and effectiveness of a drug, for the purposes for which it is advertised. New drugs must reach a certain point of approval prior to being submitted for clinical trials, however, at which point the clock is ticking for the company to recuperate their losses. They have millions of dollars in expenditures encouraging them to get the drug to market, and government policy which encourages them to go through the trials as quickly as possible while satisfying minimum FDA requirements.<\/p>\nPatent Medicine has a 400 Year History<\/h3>\n
Official Policy Encourages Quick Clinical Trials<\/h3>\n
20 Year Patent Protection<\/h3>\n